CD14 and Parkinson disease: In the case of CX3CR1 on CD14+ CD16-monocyte with respect to PD risk, the IVW method revealed a significant relationship (OR = 0.91, 95% CI = 0.86–0.96, p = 0.0003 PFDR = 0.152).